Dyne Therapeutics Inc (DYN NASDAQ) stock market data APIs
$16.9888
-0.22(-1.3%)
as of October 20, 2025
Try our APIs with
free plan!
Dyne Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Prev. Close
16.9888
Open
16.7688
High
17.1836
Low
16.4904
52 wk Range
6.36-35.68
Market Cap
2 430 M
Shares Outstanding
142 M
EPS
-0.97
Beta
1.083
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Dyne Therapeutics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Dyne Therapeutics Inc data using free add-ons & libraries
Get Dyne Therapeutics Inc Fundamental Data
Dyne Therapeutics Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -439 036 992
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-28
- EPS/Forecast: -0.94
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Dyne Therapeutics Inc News
New
Dyne cut to Perform at Oppenheimer on valuation
[Wall Street New York stock exchange stock market] alexsl Shares of Dyne Therapeutics (NASDAQ:DYN [https://seekingalpha.com/symbol/DYN]) fell on Friday after Oppenheimer downgraded the neuromuscular ...
Dyne Therapeutics rises on positive data from myotonic dystrophy trial
[Ribonucleic acid strands consisting of nucleotides - 3d illustration] Christoph Burgstedt/iStock via Getty Images * Dyne Therapeutics (NASDAQ:DYN [https://seekingalpha.com/symbol/DYN]) shares rose...
Sector Update: Health Care Stocks Decline Pre-Bell Tuesday
Health care stocks were declining pre-bell Tuesday, with the Health Care Select Sector SPDR Fund (XL PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Dyne Therapeutics Announces Additional One-Year Clinical Data Demonstrating Functional Improvement from Phase 1/2 ACHIEVE Trial of Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
- Robust improvement demonstrated across diverse set of clinical measures - - Patient-reported outcomes support clinical meaningfulness of improvements in function and strength - - Meaningful improv...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
